Page 1 of Clinical Trials for Crucell Holland BV [SPONSOR-COLLABORATORS], 21 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children
Last Updated: September 15, 2011
Condition(s): Influenza
2
Completed
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere
Last Updated: March 1, 2012
Condition(s): Influenza
3
Completed
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere
Last Updated: November 15, 2011
Condition(s): Influenza
4
Completed
Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B
Last Updated: September 15, 2011
Condition(s): Diphtheria; Pertussis; Tetanus; Hepatitis B; Haemophilus Influenzae Infections
5
Suspended
Assessment of the Safety, Tolerability, Pharmacokinetics and Immunogenicity of a Monoclonal Antibody Against the Influenza A Virus
Last Updated: September 15, 2011
Condition(s): Influenza
6
Active, not recruiting
Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination
Last Updated: September 15, 2011
Condition(s): Diphtheria; Pertussis; Tetanus; Hepatitis B; Haemophilus Infections
7
Active, not recruiting
A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model
Last Updated: March 7, 2012
Condition(s): Malaria
8
Recruiting
A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season
Last Updated: October 20, 2011
Condition(s): Influenza
9
Completed
A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children
Last Updated: September 15, 2011
Condition(s): Hepatitis A
10
Active, not recruiting
Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines
Last Updated: September 15, 2011
Condition(s): Hepatitis A
11
Completed
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere
Last Updated: January 30, 2012
Condition(s): Influenza
12
Completed
Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers
Last Updated: March 1, 2012
Condition(s): Influenza
13
Active, not recruiting
Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine
Last Updated: September 15, 2011
Condition(s): Hepatitis A
14
Completed
Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers
Last Updated: March 1, 2012
Condition(s): Influenza
15
Recruiting
Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns
Last Updated: March 20, 2012
Condition(s): Hepatitis B
16
Completed
Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents
Last Updated: March 19, 2012
Condition(s): Rabies
17
Completed
A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects
Last Updated: September 15, 2011
Condition(s): Rabies
18
Completed
Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V
Last Updated: September 15, 2011
Condition(s): Influenza
19
Completed
Safety and Immunogenicity of Influenza H9 Vaccine in Humans
Last Updated: July 20, 2009
Condition(s): Influenza
20
Suspended
Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults
Last Updated: May 17, 2012
Condition(s): Plasmodium Falciparum Malaria

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Crucell+Holland+BV

Page 1 of Clinical Trials for Crucell Holland BV [SPONSOR-COLLABORATORS], 21 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About